Form 8-K - Current report:
SEC Accession No. 0001193125-24-268137
Filing Date
2024-11-29
Accepted
2024-11-29 17:01:32
Documents
15
Period of Report
2024-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d914369d8k.htm   iXBRL 8-K 25252
2 EX-17.1 d914369dex171.htm EX-17.1 2757
  Complete submission text file 0001193125-24-268137.txt   191532

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241127.xsd EX-101.SCH 4471
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241127_def.xml EX-101.DEF 13889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241127_lab.xml EX-101.LAB 23245
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241127_pre.xml EX-101.PRE 14858
18 EXTRACTED XBRL INSTANCE DOCUMENT d914369d8k_htm.xml XML 6193
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241516833
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)